The SLUG zinc-finger protein represses E-cadherin in breast cancer. KM Hajra, DYS Chen, ER Fearon. Cancer research 62 (6), 1613-1618.
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1–associated human and mouse brain tumors. B Dasgupta, Y Yi, DY Chen, JD Weber, DH Gutmann. Cancer research 65 (7), 2755-2760.
Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. S Takeda, DY Chen, TD Westergard, JK Fisher, JA Rubens, S Sasagawa, ...Genes & development 20 (17), 2397-2409.
The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage. HC Tu, D Ren, GX Wang, DY Chen, TD Westergard, H Kim, S Sasagawa, ... Proceedings of the National Academy of Sciences 106 (4), 1093-1098.
Design, syntheses, and evaluation of Taspase1 inhibitors. JT Lee, DY Chen, Z Yang, AD Ramos, JJD Hsieh, M Bogyo. Bioorganic & medicinal chemistry letters 19 (17), 5086-5090.
Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis. DY Chen, H Liu, S Takeda, HC Tu, S Sasagawa, BA Van Tine, D Lu, ... Cancer research 70 (13), 5358-5367.
A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth. DY Chen, Y Lee, BA Van Tine, AC Searleman, TD Westergard, H Liu, ...Cancer research 72 (3), 736-746.
Extensive tumoral melanosis associated with ipilimumab-treated melanoma. K Staser, D Chen, J Solus, A Schaffer, L Cornelius, G Linette, R Fields. British Journal of Dermatology
Physicians judging medical negligence: A conflict of values. DY Chen, K Vuylsteke, IJ Kodner, D Brown, S Ray. Surgery 157 (4), 818-823